In cancers, where a sustained energy supply and lipogenic signaling are essential for tumor growth and survival, DHA-induced restriction of energy influx, together with the downregulation of Pparγ, Fabp4, Fasn, Gpr120, and Slc2a4, disrupts key pro-tumorigenic pathways. Here, SLC2A4 is linked to neoplasm.